The Case of the Shrinking Basket: Solving for the GLP-1 Shopper
Millions of shoppers just changed. Their baskets are smaller, their standards are evolving, and most brands are struggling to adapt.
GLP-1 medications aren’t just changing bodies — they’re changing buying behavior. These consumers are scrutinizing claims, bypassing familiar brands, and rebuilding their consideration sets from scratch. And they’re doing it right now, in your category, at shelf.
The only way to understand them is to watch them shop in the real world.
What We Found When We Did
Curion followed GLP-1 shoppers into real stores across the US and UK — observing what stopped them, what they read, what they reached for, and what they put back. What we learned should be on every brand manager’s radar.
Join us to find out:
- How their shrinking basket is reshaping category spend and brand loyalty
- Which front-of-pack claims earn trust — and which ones they ignore entirely
- Where the white space is for brands willing to meet this shopper on their terms
- When real-world inMarket research reveals what controlled testing simply can’t
This isn’t a trend to monitor. It’s a market shift to act on.
Built for: Brand Managers · Insights Directors · CMOs · Innovation & Category Leaders · Packaging Teams · Sales Teams
